Published in Expert Rev Anti Infect Ther on June 01, 2007
Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol (2009) 1.78
Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health (2009) 1.52
Risk factors for tuberculosis. Pulm Med (2013) 1.48
Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia. Tob Induc Dis (2010) 1.23
Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health (2012) 1.13
The SCIDOTS Project: evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes. Subst Abuse Treat Prev Policy (2011) 1.06
Addressing smoking cessation in tuberculosis control. Bull World Health Organ (2007) 1.03
Suppression of the NF-κB pathway by diesel exhaust particles impairs human antimycobacterial immunity. J Immunol (2012) 1.01
Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease. BMC Infect Dis (2013) 1.01
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
An intervention to stop smoking among patients suspected of TB--evaluation of an integrated approach. BMC Public Health (2010) 0.93
The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am (2010) 0.86
Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa. PLoS One (2012) 0.84
Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification. PLoS One (2015) 0.84
High Tobacco Use among Presumptive Tuberculosis Patients, South India: Time to Integrate Control of Two Epidemics. Osong Public Health Res Perspect (2016) 0.78
Intention to Quit Smoking and Associated Factors in Smokers Newly Diagnosed with Pulmonary Tuberculosis. Tanaffos (2016) 0.77
Risks for tuberculosis in Kazakhstan: implications for prevention. Int J Tuberc Lung Dis (2017) 0.75
A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis. BMC Infect Dis (2016) 0.75
Nicotine Impairs Macrophage Control of Mycobacterium tuberculosis. Am J Respir Cell Mol Biol (2017) 0.75
Chronic obstructive pulmonary disease and tuberculosis. Lung India (2017) 0.75
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med (2011) 5.25
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis (2007) 3.96
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis (2010) 3.71
HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res (2005) 3.05
Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis (2005) 2.91
New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn (2006) 2.89
Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest (2007) 2.87
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis (2014) 2.75
Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest (2006) 2.70
Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. PLoS Med (2013) 2.69
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med (2009) 2.55
Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J (2012) 2.45
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study. PLoS One (2011) 2.40
T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med (2010) 2.36
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One (2009) 2.34
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med (2010) 2.23
New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn (2006) 2.16
Radiological manifestations of splenic tuberculosis: a 23-patient case series from India. Indian J Med Res (2007) 2.08
Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus & occurrence of osteoporosis. Indian J Med Res (2015) 2.08
Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol (2011) 2.07
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One (2013) 2.05
Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management. Drugs (2008) 1.95
The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients. Clin Infect Dis (2011) 1.88
Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol (2006) 1.76
Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med (2010) 1.73
Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol (2005) 1.72
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur Respir J (2011) 1.68
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med (2013) 1.66
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest (2003) 1.65
Targeting persisters for tuberculosis control. Antimicrob Agents Chemother (2012) 1.65
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid. Thorax (2013) 1.64
IL-4 in tuberculosis: implications for vaccine design. Trends Immunol (2004) 1.63
Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother (2011) 1.62
Antituberculosis drugs and hepatotoxicity. Respirology (2006) 1.62
HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med (2009) 1.54
The current role of thoracic surgery in tuberculosis management. Respirology (2009) 1.52
Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med (2006) 1.52
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis (2013) 1.49
TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther (2009) 1.47
Will an unsupervised self-testing strategy for HIV work in health care workers of South Africa? A cross sectional pilot feasibility study. PLoS One (2013) 1.44
FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med (2009) 1.43
The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One (2012) 1.38
Lung function testing prediction equations: do they fit all? Chest (2008) 1.37
Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res (2012) 1.37
Seasonal pattern of tuberculosis in Hong Kong. Int J Epidemiol (2005) 1.35
Tuberculosis in the global aging population. Infect Dis Clin North Am (2010) 1.34
Topical ocular delivery of NSAIDs. AAPS J (2008) 1.25
Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med (2010) 1.23
Prevalence and risk factors of obstructive sleep apnea among middle-aged urban Indians: a community-based study. Sleep Med (2009) 1.23
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21
Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS One (2011) 1.19
Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit. BMC Pulm Med (2006) 1.19
Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting. PLoS One (2012) 1.16
Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis (2008) 1.16
Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons? PLoS One (2013) 1.16
Chikungunya fever: clinical manifestations & management. Indian J Med Res (2006) 1.14
Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res (2010) 1.13
Treatment of tuberculosis and optimal dosing schedules. Thorax (2010) 1.13
Current development and future prospects in chemotherapy of tuberculosis. Respirology (2010) 1.12
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. PLoS One (2013) 1.12
Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa. Trop Med Int Health (2010) 1.11
Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes (2014) 1.11
Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol (2006) 1.11
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs. Cochrane Database Syst Rev (2014) 1.11
Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health (2010) 1.10
Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Res (2009) 1.08
Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub-Saharan Africa. Int J Gynaecol Obstet (2010) 1.08
Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med (2010) 1.08
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb) (2011) 1.08
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? Vaccine (2005) 1.06
Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression. Am J Respir Crit Care Med (2014) 1.06
Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS One (2010) 1.06
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings. Eur Respir J (2013) 1.05
Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review. Eur Respir J (2012) 1.05
Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. PLoS One (2013) 1.05
Epidemiology of nosocomial infections in medicine intensive care unit at a tertiary care hospital in northern India. Trop Doct (2008) 1.04
Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med (2010) 1.03
Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur J Immunol (2005) 1.03
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health (2011) 1.03
Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART. Clin Dev Immunol (2010) 1.03
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.02
Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol (2006) 1.01
Management of multidrug-resistant tuberculosis: Update 2007. Respirology (2008) 1.01
Development of a simple reliable radiographic scoring system to aid the diagnosis of pulmonary tuberculosis. PLoS One (2013) 1.01
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Exposure to avian influenza H7N9 in farms and wet markets. Lancet (2013) 1.00
Subcutaneous cysticercosis. Indian J Med Res (2012) 0.99
Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am J Respir Crit Care Med (2013) 0.99
Non-invasive ventilation for acute exacerbation of COPD with very high PaCO(2): A randomized controlled trial. Lung India (2010) 0.98
Clinico-pathologic study of pulmonary carcinoid tumours--a retrospective analysis and review of literature. Respir Med (2008) 0.97
TGFbeta1 haplotypes and asthma in Indian populations. J Allergy Clin Immunol (2005) 0.97
Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinb) (2006) 0.97